STOCK TITAN
  1. Home
  2. Sec-filings
  3. AZN
  4. [Form 4] ASTRAZENECA PLC Insider Trading Activity

AstraZeneca PLC (NASDAQ: AZN) SVP gains 2 shares via incentive plan

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

AstraZeneca PLC reported that SVP, Group Controller Mani Sharma acquired 2.0000 Ordinary Shares on August 6, 2026 through a non-derivative grant under the Issuer's Share Incentive Plan. The shares were priced at GBP121.26 ($163.3400) using a GBP1.0000 to $1.3470 conversion rate, bringing direct holdings to 19267.4659 shares.

Positive

  • None.

Negative

  • None.
Insider Sharma Mani
Role SVP, Group Controller
Type Security Shares Price Value
Grant/Award Ordinary Shares F1 2 $163.34 $326.68
Holdings After Transaction: Ordinary Shares — 19,267.4659 shares (Direct)
Footnotes (1)
  1. F1. Represents the acquisition of shares pursuant to the Issuer's Share Incentive Plan at a price of GBP121.26, which has been converted from British pounds sterling to United States dollars at a conversion rate of GBP1.0000 to $1.3470 on July 31, 2026 as published by the Board of Governors of the Federal Reserve System.
Shares acquired 2.0000 Ordinary Shares Non-derivative grant on August 6, 2026
Price per share (USD) $163.3400 Converted from GBP at GBP1.0000 to $1.3470
Price per share (GBP) GBP121.26 Acquisition price under Share Incentive Plan
Shares owned after transaction 19267.4659 Direct holdings following August 6, 2026 acquisition
FX conversion rate GBP1.0000 to $1.3470 Rate as of July 31, 2026 used for price conversion
Ordinary Shares financial
"Security acquired was listed as Ordinary Shares, non-derivative"
Ordinary shares are a type of ownership stake in a company, giving shareholders a right to participate in the company’s profits and decision-making through voting. They are similar to owning a piece of a business, and their value can rise or fall based on the company's performance. Investors buy ordinary shares to potentially earn dividends and benefit from the company's growth over time.
Share Incentive Plan financial
"acquisition of shares pursuant to the Issuer's Share Incentive Plan"
A share incentive plan is a company program that gives employees or directors the chance to receive or buy company shares, often after staying with the firm or meeting performance goals. It matters to investors because it’s like giving workers a slice of the company pie to boost performance and loyalty, but issuing those slices can reduce each existing owner’s portion and change metrics such as earnings per share and share count.
conversion rate financial
"converted ... to United States dollars at a conversion rate of GBP1.0000 to $1.3470"
Conversion rate is the proportion of items, people or contracts that take a desired action out of the total possible — for example the share of website visitors who make a purchase, or the number of convertible bonds that are exchanged for shares. Investors care because it measures how effectively a business or financial instrument turns opportunity into real outcomes, like sales or share issuance, which directly affects revenue, cash flow and ownership dilution.
Board of Governors of the Federal Reserve System regulatory
"as published by the Board of Governors of the Federal Reserve System"
A seven-member federal agency that leads the U.S. central bank system and sets key interest rates and rules for banks, acting like the steering committee that guides the country’s money supply and financial stability. Investors watch its decisions because changes in interest rates and bank rules affect borrowing costs, corporate profits, stock valuations and overall market confidence, similar to how a change in road signals alters traffic flow and travel times.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Form 4 Insider Transactions: What Each Field Means →

FAQ

What transaction did AstraZeneca (AZN) executive Mani Sharma report?
Mani Sharma reported acquiring 2.0000 AstraZeneca Ordinary Shares on August 6, 2026 through a Share Incentive Plan grant. The non-derivative award increased direct ownership and reflects equity-based compensation rather than an open-market purchase. No shares were sold in this filing.

How many AstraZeneca (AZN) shares does Mani Sharma own after this Form 4?
After the reported acquisition, Mani Sharma directly holds 19267.4659 AstraZeneca Ordinary Shares. This figure reflects his direct beneficial ownership immediately following the August 6, 2026 Share Incentive Plan grant described, and does not include any additional positions not reported in this filing.

At what price were Mani Sharma's AstraZeneca (AZN) shares acquired?
The 2.0000 Ordinary Shares were acquired at GBP121.26 per share, converted to $163.3400 using a GBP1.0000 to $1.3470 conversion rate. The price and conversion were specified in connection with the Issuer's Share Incentive Plan on July 31, 2026.

Was Mani Sharma's AstraZeneca (AZN) transaction under a Rule 10b5-1 trading plan?
The Rule 10b5-1 checkbox for this Form 4 was not marked as an affirmative plan. The acquisition instead occurred pursuant to AstraZeneca's Share Incentive Plan, indicating a compensation-related share grant rather than a pre-arranged Rule 10b5-1 trading program.

What type of security did Mani Sharma acquire from AstraZeneca (AZN)?
Mani Sharma acquired 2.0000 non-derivative AstraZeneca Ordinary Shares. The shares were issued under the Issuer's Share Incentive Plan, meaning they represent actual equity rather than options or other derivatives, and immediately increased his directly held share ownership position.
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Sharma Mani
(Last)(First)(Middle)
1 FRANCIS CRICK AVENUE
CAMBRIDGE BIOMEDICAL CAMPUS
(Street)
CAMBRIDGECB2 0AA
(City)(State)(Zip)
UNITED KINGDOM
(Country)		2. Issuer Name and Ticker or Trading Symbol
ASTRAZENECA PLC [ AZN ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
SVP, Group Controller
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
08/06/2026		6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Ordinary Shares08/06/2026A2A$163.34(1)19,267.4659D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. Represents the acquisition of shares pursuant to the Issuer's Share Incentive Plan at a price of GBP121.26, which has been converted from British pounds sterling to United States dollars at a conversion rate of GBP1.0000 to $1.3470 on July 31, 2026 as published by the Board of Governors of the Federal Reserve System.
/s/ Mani Sharma08/07/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR